AeroVironment Stock Soared on a Blowout Quarter. Is the Drone Boom Just Getting Started?

AeroVironment reported fiscal Q4 revenue of $641.6M (+133% YoY; ~+31% organic) with adjusted EPS of $1.84 (vs. $1.61), and funded backlog rose to $1.2B from $726.6M (+~65%) with full-year bookings of $2.7B versus ~$2B revenue (book-to-bill 1.4). Management sees fiscal 2027 revenue of $2.125B to $2.225B (midpoint implies ~10% growth) and expects its counter-UAS business to scale meaningfully over 3–5 years. Shares jumped >20% to around $171 on the results.

Analysis

The key economic read-through is not just better defense demand, but a potential budget reallocation inside the counter-UAS ecosystem: layered air defense, RF jamming, directed energy, and kinetic interceptors are pulling spend away from single-point drone platforms and toward integrated kill chains. That favors AVAV in the near term because it now has scale, backlog visibility, and a credible systems portfolio; it also raises the bar for smaller pure-play drone names that depend on a cleaner growth narrative and have less program diversification.

The next 1-3 months, the stock should trade more on whether FY27 guidance proves conservative than on the quarter itself. The risk is that backlog quality is less durable than the headline suggests: acquisitions can inflate backlog, and government programs often slip between award, procurement, and revenue recognition. If counter-drone remains a talking point rather than a real revenue step-up, the market will start fading the multiple before the next catalyst.

My contrarian read is that consensus may be underestimating how long it takes to convert this theme into cash flow. Directed energy and advanced interceptors are strategic, but procurement cycles can be glacial; that means the market may be pricing a 2-3 year structural growth story against a 6-9 month execution story. The thesis is falsified if organic growth decelerates sharply in the next two quarters, backlog conversion weakens, or adjusted margins fail to hold near current levels as integration costs and R&D step-up bite.

Key Decisions for Investors

• Do not chase the gap higher; wait for a 8-12% post-event retrace in AVAV and then buy a small core position for a 6-12 month hold, with the thesis anchored on backlog conversion rather than further multiple expansion.
• For cleaner upside with defined risk, use AVAV call spreads into the next 2-3 quarters of defense budget newsflow; the payoff is best if management proves counter-UAS is becoming a material segment, not just a slide deck theme.
• Relative-value idea: long AVAV / short XAR or ITA over the next 3-6 months if you want to own idiosyncratic growth while hedging broader defense beta; this works if AVAV keeps executing and the rest of the sector remains range-bound.
• Set a watch item on AVAV’s next two earnings calls: if organic growth drops below the low-20%s or adjusted EBITDA margin rolls over, reduce exposure quickly; that would signal the market has already pulled forward too much of the multiyear story.